share_log

On November 22, Oncternal Therapeutics Announced That Nasdaq Plans To Delist Its Stock On December 3, Nasdaq Classified The Company As "Public Shell," Following Its Decision To Lay Off Employees And Explore Strategic Alternatives-Filing

On November 22, Oncternal Therapeutics Announced That Nasdaq Plans To Delist Its Stock On December 3, Nasdaq Classified The Company As "Public Shell," Following Its Decision To Lay Off Employees And Explore Strategic Alternatives-Filing

11月22日,oncternal therapeutics宣布,纳斯达克计划在12月3日摘牌其股票,纳斯达克将该公司视为"公共外壳",并在决定裁员和探索战略替代方案后对其进行分类。
Benzinga ·  2024/11/25 03:30

纳斯达克将向美国证券交易委员会提交摘牌通知。oncternal已表示将不对该决定提出上诉。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发